Wegovy(Semaglutide)
NVO
Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Novo Nordisk A/S
$301.2M
Medicare cost, 2024
$301.2M
Medicare cost, 2024
Medicare drug plans spent $301.2 million on Wegovy (semaglutide) in 2024, for 211,490 prescriptions and refills filled by 52,936 patients. Spending rose 150651% from 2023 to 2024. It was first approved in 2021. California accounts for the most spending ($25.7 million, 9% of the total).
Medicare cost, 2024
$301.2M
+150651.0% from 2023
Prescriptions
211K
$1,424.00 per claim
Patients
53K
40,963 prescribers
Total spending, 2024
$301.3M
$5,688.78 per patient
Questions and answers
How much does Medicare spend on Wegovy?
Medicare prescription drug plans paid $301.2M for Wegovy in 2024, for 211,490 prescriptions and refills to 52,936 patients (up 150651.0% from 2023). The average cost per claim was $1,424.00.
Which state spends the most on Wegovy?
California had the highest Medicare cost for Wegovy in 2024: $25.7M for 18,355 claims, followed by New York ($25.3M).
Who prescribes Wegovy the most?
Amanda G Fontenot, internal medicine in Marrero, LA, had the highest Medicare cost for Wegovy in 2024: 273 claims costing $372K.
Who makes Wegovy?
Wegovy is made by Novo Nordisk A/S (NVO), listed in the Medicare spending data as Novo Nordisk.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Wegovy was $301.3M in 2024, the highest year shown.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Wegovy, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Amanda G Fontenot Marrero, LA | Internal Medicine | 273 | 63 | $372K |
| Mitzi B Rubin Marietta, GA | Family Practice | 205 | 45 | $287K |
| Shona V Velamakanni Naples, FL | Cardiology | 190 | 49 | $285K |
| Allison Steele Scottsdale, AZ | Family Practice | 176 | 37 | $254K |
| Lindsay M Wiles Tampa, FL | Family Practice | 171 | 35 | $232K |
| Jessica C Inwood Fall River, MA | Family Practice | 159 | 56 | $229K |
| Rachel S Dauterive New Orleans, LA | Preventive Medicine | 166 | 41 | $221K |
| Kayla A Northam Lebanon, NH | Nurse Practitioner | 156 | 52 | $217K |
| Kristen Cummings Fall River, MA | Nurse Practitioner | 149 | 60 | $199K |
| Kamal Shemisa Cincinnati, OH | Internal Medicine | 136 | 27 | $188K |
| Chika V Anekwe Boston, MA | Preventive Medicine | 120 | 31 | $186K |
| Jessica Breen Sheth Fall River, MA | Physician Assistant | 126 | 39 | $170K |
| Lance E Sullenberger Albany, NY | Cardiology | 113 | 24 | $165K |
| Jennifer Sykora Fairhope, AL | Internal Medicine | 105 | 24 | $144K |
| Natasha Martin Fall River, MA | Nurse Practitioner | 98 | 34 | $137K |
| Stephanie M Persondek Liberty Lake, WA | Obstetrics & Gynecology | 93 | 21 | $135K |
| Pavan Malur Baton Rouge, LA | Cardiology | 95 | 30 | $134K |
| Janine V Kyrillos Bala Cynwyd, PA | Internal Medicine | 71 | 16 | $131K |
| Sajid Mehmood Sunnyvale, CA | Family Practice | 90 | 15 | $131K |
| Justine Tuttle Centereach, NY | Physician Assistant | 92 | 15 | $122K |
| Sarah E Santana Stamford, CT | Physician Assistant | 68 | 20 | $120K |
| Kelly Minus Brooklyn, NY | Nurse Practitioner | 85 | 36 | $117K |
| Robert Mormando Port Jefferson Station, NY | Internal Medicine | 70 | 15 | $115K |
| Jennifer D Schwartz Fall River, MA | Internal Medicine | 72 | 25 | $114K |
| Crystal L O'Connell Fall River, MA | Nurse Practitioner | 82 | 26 | $112K |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 46 | 142 | 47 | $200K |
| 2024 | 40,963 | 211,490 | 52,936 | $301.2M |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novo Nordisk | 211,575 | $301.3M |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 13
- RxNorm concept IDs
- 2553501, 2553506
- Application numbers
- NDA215256, NDA218316
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 78,023 side-effect reports named semaglutide, the active ingredient of Wegovy (reports from 2013 on). 39,105 of them (50.1%) were serious, 1,364 named a death and 15,565 named a hospital stay. The reactions named most often were nausea, off label use and vomiting. 67,168 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
78,023
20,019 in 2025 (+39.9% from 2024)
Serious
50.1%
39,105 reports
Deaths named
1,364
1.7% of reports
Hospital stays
15,565
19.9% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Wegovy?
78,023 reports from 2013 through September 2026 named semaglutide, the active ingredient of Wegovy. 39,105 of them (50.1%) were serious, 1,364 named a death and 15,565 named a hospital stay.
What are the most reported side effects of Wegovy?
11,150 reports named nausea, the reaction named most often, followed by off label use (7,890) and vomiting (7,332). In the last 5 years the reaction named most often was nausea (9,222 reports). A report can name several reactions.
How many side-effect reports named Wegovy in 2025?
20,019 reports were received in 2025 (+39.9% from 2024). 2026 so far: 17,010 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Wegovy caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Wegovy caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with semaglutide: Ozempic, Rybelsus
- Makers on the stock market:
NVO·NVO drug pipeline - Drug approvals (3 approvals on file for semaglutide) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (semaglutide) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.